Background: Johnson and Dillon (2011) provided a model-based comparison of current generic hearing aid prescriptive methods for adults with hearing loss based on the attributes of speech intelligibility, loudness, and bandwidth. Purpose: This study compared the National Acoustic Laboratories-Non-linear 2 (NAL-NL2) and Cambridge Method for Loudness Equalization 2-High-Frequency (CAM2) prescriptive methods using adult participants with less high-frequency hearing loss than Johnson and Dillon (2011). Of study interest was quantification of prescribed audibility, speech intelligibility, and loudness. The preferences of participants for either NAL-NL2 or CAM2 and preferred deviations from prescribed settings are also reported. Research Design: Using a single-blind, counter-balanced, randomized design, preference judgments for the prescriptive methods with regard to sound quality of speech and music stimuli were obtained. Preferred gain adjustments from the prescription within the 4-10 kHz frequency range were also obtained from each participant. Speech intelligibility and loudness model calculations were completed on the prescribed and adjusted amplification. Study Sample: Fourteen male Veterans, whose average age was 65 yr and whose hearing sensitivity averaged normal to borderline normal through 1000 Hz sloping to a moderately severe sensorineural loss, served as participants. Data Collection and Analysis: Following a brief listening time (∼10 min), typical of an initial fitting visit, the participants made paired comparison of sound quality between the NAL-NL2 and CAM2 prescriptive settings. Participants were also asked to modify each prescription in the range of 4-10 kHz using an overall gain control and make subsequent comparisons of sound quality preference between prescriptive and adjusted settings. Participant preferences were examined with respect to quantitative analysis of loudness modeling, speech intelligibility modeling, and measured high-frequency bandwidth audibility. Results: Consistent with the lack of difference in predicted speech intelligibility between the two prescriptions, sound quality preferences on the basis of clarity were split across participants while some participants did not have a discernable preference. Considering sound quality judgments of pleasantness, the majority of participants preferred the sound quality of the NAL-NL2 (8 of 14) prescription instead of the CAM2 prescription (2 of 14). Four of the 14 participants showed no preference on the basis of pleasantness for either prescription. Individual subject preferences were supported by loudness modeling that indicated NAL-NL2 was the softer of the two prescriptions and CAM2 was the louder. CAM2 did provide more audibility to the higher frequencies (5-8 kHz) than NAL-NL2. Participants turned the 4-10 kHz gain recommendation of CAM2 lower, on average, by a significant amount of 4 dB when making adjustments while no significant adjustment was made to the initial NAL-NL2 recommendation. Conclusions: NAL-NL2 prescribed gains were more often preferred at the initial fitting by the majority of participating veterans. For those patients with preference for a louder fitting than NAL-NL2, CAM2 is a good alternative. When the participant adjustment from the prescription between 4 and 10 kHz exceeded 4 dB from either NAL-NL2 (2 of 14) or CAM2 (11 of 14), the participants demonstrated a later preference for that adjustment 69% of the time. These findings are viewed as limited evidence that some individuals may have a preference for high-frequency gain that differs from the starting prescription.

No description available.

No description available.

The hearing and understanding problems of the people with high frequency hearing loss are covered within the scope of this thesis. For overcoming these problems, two main studies, developing hearing loss simulation (HLS) and applying new frequency lowering methods (FLMs) were carried out. HLS was developed with the suprathreshold effects and new FLMs were applied with different combinations of the FLMs. For evaluating the studies, modified rhyme test (MRT) and speech intelligibility index (SII) were used as subjective and objective measures, respectively. Before both of the studies, offline studies were carried out for specifying the significant parameters and values for using in MRT. For the HLS study, twelve hearing impaired subjects listened to unprocessed sounds and thirty six normal hearing subjects listened to simulated sounds. In the evaluation of the HLS, both measures gave similar and consistent results for both unprocessed and simulated sounds. In FLMs study, hearing impaired subjects were simulated and normal hearing subjects listened to frequency lowered sounds with the specified methods, parameters and values. All FLMs were compared with the standard method of hearing aids (amplification) for five different noisy environments. FLMs satisfied 83% success of higher speech intelligibility improvement than amplification in all cases. As a conclusion, the necessity of using subject-specific FLMs was shown to achieve higher intelligibility than with amplification only. Accordingly, a methodology for selection of the values of parameters for different noisy environments and for different audiograms was developed.

Click-evoked otoacoustic emission (CEOAE) input/output (I/O) functions were measured in ears with normal hearing and in ears with sensorineural hearing loss above 2000 Hz. The low- to midfrequency CEOAEs obtained from the ears with high-frequency hearing loss were significantly reduced in level compared to the CEOAEs obtained from the ears with normal hearing even though there were no significant group differences in the 250-2000 Hz pure-tone thresholds. The findings are discussed within the context of two hypotheses that explain the low- to midfrequency reduction in transient-evoked otoacoustic emission (TEOAE) magnitude: (1) subclinical damage to the more apical regions of the cochlea not detected by behavioral audiometry, or (2) trauma to the basal region of the cochlea that affects the generation of low-frequency emissions. It is proposed that localized damage at basal cochlear sites affects the generation of low- to midfrequency CEOAE energy.

INTRODUÇÃO: A Síndrome da Imunodeficiência Adquirida é causada pelo vírus da imunodeficiência humana, um retrovírus específico que afeta o sistema imunológico, propiciando a ocorrência de diversas infecções oportunistas e podendo afetar também o sistema nervoso auditivo central. OBJETIVO: Avaliar as vias periférica e central do sistema auditivo em indivíduos adultos com HIV/AIDS. MÉTODOS: Foram avaliados 25 indivíduos com HIV/AIDS e 25 indivíduos do grupo controle, sendo estes submetidos à avaliação audiológica convencional, audiometria em altas frequências, emissões otoacústicas por transiente, supressão das emissões otoacústicas, potenciais evocados auditivos de tronco encefálico, média latência e Potencial Cognitivo (P300). RESULTADOS: O grupo estudo apresentou alterações em todas as avaliações realizadas, enquanto que o grupo controle apresentou alterações na audiometria em altas frequências, supressão das emissões otoacústicas, potencial evocado auditivo de média latência e P300. A comparação dos resultados normais e alterados obtidos entre os grupos apresentou diferença estatisticamente significante para a audiometria tonal convencional, audiometria em altas frequências, timpanometria, pesquisa dos reflexos acústicos, emissões otoacústicas, supressão das emissões otoacústicas e potencial evocado auditivo de tronco encefálico, sendo também possível observar uma tendência à diferença estatisticamente significante no P300. Com relação aos tipos de alteração, o grupo estudo apresentou maior ocorrência de perda auditiva neurossensorial na avaliação audiológica convencional, alterações sugestivas de comprometimento de orelha média e tronco encefálico concomitantemente no potencial evocado auditivo de tronco encefálico, alteração do tipo ambas (efeito eletrodo e efeito orelha ocorrendo concomitantemente) no potencial evocado auditivo de média latência e alterações por aumento de latência no P300. Com relação à análise quantitativa pode-se verificar que na comparação dos resultados obtidos entre os grupos houveram diferenças estatisticamente significantes para todos os limiares obtidos na audiometria tonal convencional, bem como na audiometria em altas frequências; no potencial evocado auditivo de tronco encefálico para a latência das ondas I, III, V, e interpicos I-V e III-V; no potencial evocado auditivo de média latência para a latência da onda Pa nas modalidades C4-A1 e C4-A2 e no P300 para a latência dessa onda. CONCLUSÃO: Indivíduos com HIV/AIDS apresentam alterações na avaliação audiológica convencional, audiometria em altas frequências, emissões otoacústicas, supressão das emissões otoacústicas e nos potenciais evocados auditivos, sugerindo comprometimento tanto da via auditiva periférica como da via auditiva central. / INTRODUCTION: The Acquired Immunodeficiency Syndrome is caused by the human immunodeficiency virus, a specific retrovirus that affects the immunological system allowing the emergence of several opportunistic infections, and that may also affect the central auditory nervous system. AIM: To assess the peripheral and central auditory pathways of the auditory system of individuals with HIV/AIDS. METHOD: 25 individuals with HIV/AIDS and 25 individuals from a control group were evaluated by conventional audiological assessment, high-frequency audiometry, transient otoacoustic emissions, suppression of otoacoustic emissions, brainstem auditory evoked potential, middle latency auditory evoked potential, and Cognitive Potential (P300). RESULTS: The study group presented abnormal results in all evaluations while the control group presented abnormal results in high-frequency audiometry, otoacoustic emission suppression, middle latency auditory evoked potential and P300. The comparison of normal and abnormal results between the groups showed statistically significant difference in conventional pure tone audiometry, high-frequency audiometry, tympanometry, acoustic reflexes, otoacoustic emissions, otoacoustic emissions suppression, and brainstem auditory evoked potential; it was also observed a tendency to statistically significant difference in P300. Concerning the types of alterations, the study group presented higher incidence of sensorineural hearing loss in the conventional audiological assessment; alterations suggestive of concomitant middle ear and brainstem disorders in the brainstem auditory evoked potential; concomitant electrode effect and ear effect in the middle latency auditory evoked potential; and increased latency in P300. In the quantitative analysis it was verified that in the comparison of results between the groups there were statistically significant differences for all thresholds obtained in the conventional pure tone audiometry as well as in the high-frequency audiometry; in the brainstem auditory evoked potential for the latency of waves I, III, V, and interpeaks I-V and III-V; in the middle latency for the latency of wave Pa in modalities C4-A1 and C4- A2; and in P300 latency. CONCLUSION: Individuals with HIV/AIDS present alteration in conventional audiological assessment, high-frequency audiometry, otoacoustic emission, otoacoustic emission suppression, and in auditory evoked potentials suggesting abnormalities of both, the peripheral and the central auditory pathways.

INTRODUÇÃO: A Síndrome da Imunodeficiência Adquirida é causada pelo vírus da imunodeficiência humana, um retrovírus específico que afeta o sistema imunológico, propiciando a ocorrência de diversas infecções oportunistas e podendo afetar também o sistema nervoso auditivo central. OBJETIVO: Avaliar as vias periférica e central do sistema auditivo em indivíduos adultos com HIV/AIDS. MÉTODOS: Foram avaliados 25 indivíduos com HIV/AIDS e 25 indivíduos do grupo controle, sendo estes submetidos à avaliação audiológica convencional, audiometria em altas frequências, emissões otoacústicas por transiente, supressão das emissões otoacústicas, potenciais evocados auditivos de tronco encefálico, média latência e Potencial Cognitivo (P300). RESULTADOS: O grupo estudo apresentou alterações em todas as avaliações realizadas, enquanto que o grupo controle apresentou alterações na audiometria em altas frequências, supressão das emissões otoacústicas, potencial evocado auditivo de média latência e P300. A comparação dos resultados normais e alterados obtidos entre os grupos apresentou diferença estatisticamente significante para a audiometria tonal convencional, audiometria em altas frequências, timpanometria, pesquisa dos reflexos acústicos, emissões otoacústicas, supressão das emissões otoacústicas e potencial evocado auditivo de tronco encefálico, sendo também possível observar uma tendência à diferença estatisticamente significante no P300. Com relação aos tipos de alteração, o grupo estudo apresentou maior ocorrência de perda auditiva neurossensorial na avaliação audiológica convencional, alterações sugestivas de comprometimento de orelha média e tronco encefálico concomitantemente no potencial evocado auditivo de tronco encefálico, alteração do tipo ambas (efeito eletrodo e efeito orelha ocorrendo concomitantemente) no potencial evocado auditivo de média latência e alterações por aumento de latência no P300. Com relação à análise quantitativa pode-se verificar que na comparação dos resultados obtidos entre os grupos houveram diferenças estatisticamente significantes para todos os limiares obtidos na audiometria tonal convencional, bem como na audiometria em altas frequências; no potencial evocado auditivo de tronco encefálico para a latência das ondas I, III, V, e interpicos I-V e III-V; no potencial evocado auditivo de média latência para a latência da onda Pa nas modalidades C4-A1 e C4-A2 e no P300 para a latência dessa onda. CONCLUSÃO: Indivíduos com HIV/AIDS apresentam alterações na avaliação audiológica convencional, audiometria em altas frequências, emissões otoacústicas, supressão das emissões otoacústicas e nos potenciais evocados auditivos, sugerindo comprometimento tanto da via auditiva periférica como da via auditiva central. / INTRODUCTION: The Acquired Immunodeficiency Syndrome is caused by the human immunodeficiency virus, a specific retrovirus that affects the immunological system allowing the emergence of several opportunistic infections, and that may also affect the central auditory nervous system. AIM: To assess the peripheral and central auditory pathways of the auditory system of individuals with HIV/AIDS. METHOD: 25 individuals with HIV/AIDS and 25 individuals from a control group were evaluated by conventional audiological assessment, high-frequency audiometry, transient otoacoustic emissions, suppression of otoacoustic emissions, brainstem auditory evoked potential, middle latency auditory evoked potential, and Cognitive Potential (P300). RESULTS: The study group presented abnormal results in all evaluations while the control group presented abnormal results in high-frequency audiometry, otoacoustic emission suppression, middle latency auditory evoked potential and P300. The comparison of normal and abnormal results between the groups showed statistically significant difference in conventional pure tone audiometry, high-frequency audiometry, tympanometry, acoustic reflexes, otoacoustic emissions, otoacoustic emissions suppression, and brainstem auditory evoked potential; it was also observed a tendency to statistically significant difference in P300. Concerning the types of alterations, the study group presented higher incidence of sensorineural hearing loss in the conventional audiological assessment; alterations suggestive of concomitant middle ear and brainstem disorders in the brainstem auditory evoked potential; concomitant electrode effect and ear effect in the middle latency auditory evoked potential; and increased latency in P300. In the quantitative analysis it was verified that in the comparison of results between the groups there were statistically significant differences for all thresholds obtained in the conventional pure tone audiometry as well as in the high-frequency audiometry; in the brainstem auditory evoked potential for the latency of waves I, III, V, and interpeaks I-V and III-V; in the middle latency for the latency of wave Pa in modalities C4-A1 and C4- A2; and in P300 latency. CONCLUSION: Individuals with HIV/AIDS present alteration in conventional audiological assessment, high-frequency audiometry, otoacoustic emission, otoacoustic emission suppression, and in auditory evoked potentials suggesting abnormalities of both, the peripheral and the central auditory pathways.